294. Congenital diaphragmatic hernia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 26 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 14
Congenital diaphragmatic hernia and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
294 | Congenital diaphragmatic hernia |
13 | Multiple sclerosis/Neuromyelitis optica |
6 | Parkinson disease |
21 | Mitochondrial disease |
299 | Cystic fibrosis |
2 | Amyotrophic lateral sclerosis |
46 | Malignant rheumatoid arthritis |
51 | Scleroderma |
96 | Crohn disease |
97 | Ulcerative colitis |
63 | Idiopathic thrombocytopenic purpura |
282 | Congenital dyserythropoietic anemia |
265 | Lipodystrophy |
225 | Congenital nephrogenic diabetes insipidus |
78 | Hypopituitarism |
113 | Muscular dystrophy |
226 | Interstitial cystitis with Hunners ulcer |
85 | Idiopathic interstitial pneumonia |
86 | Pulmonary arterial hypertension |
71 | Idiopathic osteonecrosis of the femoral head |
166 | Pseudoxanthoma elasticum |
124 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy |